FITB vs PTGX · P/E 17, rev $3.37B vs rev $269.8M
Fifth Third Bancorp (FITB) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the FITB and PTGX stock pages for the full models.
Not investment advice.